News

Dr. Patrick Sullivan, Professor in Epidemiology in The Rollins School of Public Health at Emory University, has spent the bulk of his career studying HIV/AIDS, specifically about how to effectively...

Washington DC continues to battle some of the highest sexually transmitted infection rates in the country, regularly leading the country in gonorrhea and chlamydia rates. In a continued effort to...

John Wiesman, the Washington State Secretary of Health has issued new orders (20-02) regarding staff and patient testing of COVID-19. To make sure that all facilities can comply with the orders, the State of Washington has contracted with Molecular Testing Labs (Molecular) and the University of Washington Department of Virology (UW Virology) to provide this testing.

In years past, determining the best medication for a patient was often reduced to a game of trial and error. Several factors — whether that’s age, lifestyle choices, dietary habits, or environmental influences — can impact how someone responds to a particular medication, so what works for one individual may cause debilitating side effects in another.

Washington State has been at the forefront of financial assistance for the prevention of HIV, offering one of the most comprehensive set of benefits to any resident at risk of...

In the coming weeks we hope to provide SARS-CoV-2 testing to health departments, hospitals, commercial partners, providers, and patients. We have resources to meet the high demand for testing that is anticipated. Our at-home self-collect capabilities will bring the test directly to the patient, establishing access to care without barriers.

Molecular Testing Labs (Molecular), a laboratory specializing in sexually transmitted infection (STI) testing utilizing dried blood spots, announces receipt of the Idaho Global Entrepreneurial Mission (IGEM) grant in partnership with Boise State University (BSU). 

The American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT®) Proprietary Laboratory Analyses (PLA) code for detection of high-risk Human Papillomavirus (HPV) in urine samples from male patients.